Clinical Trials Browser

Unknown × Leukemia × Dasatinib × Clear all

NCT03564470 2022-07-01

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00112775 2011-06-07

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase